benzaldehyde has been researched along with Leishmaniasis in 1 studies
Leishmaniasis: A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL).
Excerpt | Relevance | Reference |
---|---|---|
"Leishmaniasis is a major health problem that affects more than 12 million people." | 1.38 | Benzaldehyde thiosemicarbazone derived from limonene complexed with copper induced mitochondrial dysfunction in Leishmania amazonensis. ( Britta, EA; Dias-Filho, BP; Nakamura, CV; Sernaglia, RL; Silva, AP; Silva, CC; Ueda-Nakamura, T, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Britta, EA | 1 |
Silva, AP | 1 |
Ueda-Nakamura, T | 1 |
Dias-Filho, BP | 1 |
Silva, CC | 1 |
Sernaglia, RL | 1 |
Nakamura, CV | 1 |
1 other study available for benzaldehyde and Leishmaniasis
Article | Year |
---|---|
Benzaldehyde thiosemicarbazone derived from limonene complexed with copper induced mitochondrial dysfunction in Leishmania amazonensis.
Topics: Animals; Antiprotozoal Agents; Benzaldehydes; Copper; Humans; Leishmania; Leishmaniasis; Lipid Perox | 2012 |